Non-receptor tyrosine kinase Etk regulation of drug resistance in small-cell lung cancer

European Journal of Cancer

Volumn 46, Issue 3, 2010, Pages 636-641

  Guo, Linlang ^a   Zhou, Yuanyuan ^a   Sun, Yanqin ^a   Zhang, Fan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Chemoresistance; Etk; Small cell lung cancer

Indexed keywords

BONE MARROW X KINASE; MESSENGER RNA; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BCL-X PROTEIN; DRUG RESISTANCE, NEOPLASM; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 75149168360     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.11.009     Document Type: Article

References (22)

1. Govindan R., Page N., Morgensztern D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24 (2006) 4539-4544
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 59 (2009) 225-249
3. Samson D.J., Seidenfeld J., Simon G.R., et al. Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 3 Suppl. (2007) 314S-323S
4. Simon G.R., Turrisi A., and American College of Chest Physicians. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132 3 Suppl. (2007) 324S-339S
5. Sørensen M., Felip E., and ESMO Guidelines Working Group. Small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol Suppl. 4 (2009) 71-72
6. Tamagnone L., Lahtinen I., and Mustonen T. Et al. BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2. Oncogene 9 (1994) 3683-3688
7. Smith C.I., Islam T.C., Mattsson P.T., et al. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 23 (2001) 436-446
8. Qiu Y., and Kung H.J. Signaling network of the Btk family kinases. Oncogene 19 (2000) 5651-5661
9. Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Fact Rev 10 (1999) 267-280
10. Wen X., Lin H.H., Shih H.M., Kung H.J., and Ann D.K. Kinase activation of the non-receptor tyrosine kinase Etk/BMX alone is sufficient to transactivate STAT-mediated gene expression in salivary and lung epithelial cells. J Biol Chem 274 (1999) 38204-38210
11. Robinson D., He F., Pretlow T., and Kung H.J. A tyrosine kinase profile of prostate carcinoma. PNAS 93 (1996) 5958-5962
12. Xue L.Y., Qiu Y., He J., Kung H.J., and Oleinick N.L. Etk/Bmx, a PH-domain containing tyrosine kinase, protects prostate cancer cells from apoptosis induced by photodynamic therapy or thapsigargin. Oncogene 18 (1999) 3391-3398
13. Jiang T., Guo Z., Dai B., et al. Bi-directional regulation between tyrosine kinase Etk/BMX and tumor suppressor p53 in response to DNA damage. J Biol Chem 279 (2004) 50181-50189
14. Ekman N., Arighi E., Rajantie I., et al. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner. Oncogene 19 (2000) 4151-4158
15. Mirski S.E., Gerlach J.H., and Cole S.P. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 47 (1987) 2594-2598
16. Cole S.P., Bhardwaj G., Gerlach J.H., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258 (1992) 1650-1654
17. Slovak M.L., Ho J.P., Bhardwaj G., et al. Localization of a novel multidrug resistance-associated gene in the HT1080/DR4 and H69AR human tumor cell lines. Cancer Res 53 (1993) 3221-3225
18. Chen E.K., Huang L.M., Kung H.J., Ann D.K., and Shih H.M. The role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cells. Oncogene 23 (2004) 1854-1862
19. Kaiser U., Schilli M., Haag U., et al. Expression of bcl-2-protein in small cell lung cancer. Lung cancer 15 (1996) 31-40
20. Wang D.G., Johnston C.F., Sloan J.M., and Buchanan K.D. Expression of bcl-2 in lung neuroendocrine tumors: comparison with p53. J Pathol 184 (1998) 247-251
21. Eerola A.K., Tormanen U., Rainio P., et al. Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity. J Pathol 181 (1997) 172-177
22. Chen R., Kim O., Li M., et al. Regulation of the PH-domain-containing tyrosine kinase Etk by focal adhesion kinase through the FERM domain. Nat Cell Biol 3 (2001) 439-444